Genus

JUN 18, 2026 · REGULATORY LABEL UPDATE

FDA supplemental approval: Hydromorphone Hydrochloride (REMS)

U.S. Food and Drug Administration

FDA supplemental approval of a Risk Evaluation and Mitigation Strategy (REMS) for hydromorphone hydrochloride tablets; this is a regulatory action, not a clinical efficacy study.